Trial intelligence / Profile preview

Gemcitabine plus Cisplatin vs 5-Fluorouracil plus Cisplatin in Recurrent or Metastatic Nasopharyngeal Carcinoma

NCT01528618Phase 3Completed

Sponsor
Sun Yat-sen University
Start
Feb 2012
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of gemcitabine in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Feb 2012; status: completed.

02

Drugs

gemcitabine
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT01528618.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01528618.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call